hdz_47
Death to society
- Joined
- Mar 27, 2026
- Posts
- 76
- Reputation
- 57
What is LOX-435?
LOX-435 is a investigational oral which wasd developed as a therapy for solid tumors, it functions by selectively blocking fgfr3 > reducing off target effects on other fgfr isoforms.
What does fgfr-3 inhibiting do?
Fgfr-3 limits the proloferation of chrondrocytes in growth plates, by inhibiting this gene it relieves the brake on chrondrocytes leading to improved endochondral bone and increased bone elongation.
Why might LOX-435 be better than erda?
Unlike LOX-435, erdafitnib is a pan-fgfr inhibitor. This causes unnecessary toxicity from inhibiting the fgfr1/2/4 genes. LOX-435 is a highly selective fgfr-3 inhibitor which makes it a way safer option.
Summary
LOX-435 is a promising investigational selective fgfr-3 inhibitor with a better saftey-profile than erdafitnib making it a great additive to your own stack.
LOX-435 is a investigational oral which wasd developed as a therapy for solid tumors, it functions by selectively blocking fgfr3 > reducing off target effects on other fgfr isoforms.
What does fgfr-3 inhibiting do?
Fgfr-3 limits the proloferation of chrondrocytes in growth plates, by inhibiting this gene it relieves the brake on chrondrocytes leading to improved endochondral bone and increased bone elongation.
Why might LOX-435 be better than erda?
Unlike LOX-435, erdafitnib is a pan-fgfr inhibitor. This causes unnecessary toxicity from inhibiting the fgfr1/2/4 genes. LOX-435 is a highly selective fgfr-3 inhibitor which makes it a way safer option.
Summary
LOX-435 is a promising investigational selective fgfr-3 inhibitor with a better saftey-profile than erdafitnib making it a great additive to your own stack.
